ArticleFoods (Basel, Switzerland)2026
Image-Based Morphometric Analysis of Human Milk Fat Globules Versus Laser Diffraction.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Human milk fat globules (MFGs)' size characterization is key for evaluating milk quality and processing effects. Laser diffraction (LD) is widely used for particle size analysis but provides limited morphological information. This study applied image-based morphometric analysis (IBMA) to characterize MFGs' size and shape distributions in human milk and compared the results with LD measurements. Milk samples from 12 women delivering term and preterm infants were analyzed. LD was performed using a Mastersizer 3000 (Malvern Panalytical, Malvern, UK) and IBMA using a Morphologi 4 (Malvern Panalytical, Malvern, UK), acquiring 2D images at 20× magnification covering particle sizes from ~1.5 to 130 µm. IBMA classified MFGs as individual particles (IP) (HS circularity ≥ 0.920; circle equivalent diameter < 25 µm) or agglomerates (HS circularity < 0.920; solidity < 0.970), extracting descriptors including circularity, elongation, and solidity. IP predominated, while agglomerates represented ~15% of particles. Number-mean diameters (D[1,0]) were 4.91 µm (total), 4.36 µm (IP), and 8.00 µm (agglomerates). Volume-weighted particle diameters (D[4,3]) were 7.21 µm for IP and 14.02 µm for agglomerates. The highest level of agreement between methods was observed for IP D[4,3], although minor differences may be clinically relevant. IBMA and LD provide complementary information; however, IBMA uniquely enables the characterization of MFG structural organization, including the identification of agglomerates, which cannot be resolved by LD. This added level of structural detail may have important implications for understanding the digestibility of human milk, particularly in preterm populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.